Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxide- induced brain damage in mice

H. Ishimaru, A. Katoh, H. Suzuki, T. Fukuta, T. Kameyama, Toshitaka Nabeshima

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The mechanism of neurodegeneration and the possible therapeutic amelioration were investigated in a model induced by successive carbon monoxide (CO) exposures. Successive CO exposures resulted in a consistent pattern of degeneration of hippocampal CA1 pyramidal cells, which was quantified using an image analyzer. Competitive and noncompetitive antagonists of N-methyl-D-aspartate (NMDA) receptors, cyclopentenophenanthrene, (+)-5-methyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten,5,10-imine maleate and an antagonist of glycine binding sites, 7-chlorokynurenic acid, significantly reduced the CO-induced neurodegeneration. Ifenprodil (a antagonist of polyamine binding sites) and glycine had no effect. From these results, it is clear that NMDA receptor/ion channel complex is involved in the mechanism of CO-induced neurodegeneration, and that glycine binding site antagonist as well as NMDA competitive and noncompetitive antagonists may have neuroprotective properties in neurological disorders associated with overactivation of NMDA receptors.

Original languageEnglish
Pages (from-to)349-352
Number of pages4
JournalJournal of Pharmacology and Experimental Therapeutics
Volume261
Issue number1
Publication statusPublished - 01-01-1992
Externally publishedYes

Fingerprint

Carbon Monoxide
N-Methyl-D-Aspartate Receptors
Glycine
Binding Sites
Brain
Imines
Pyramidal Cells
Polyamines
N-Methylaspartate
Nervous System Diseases
Ion Channels
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

@article{62e736cb4b6c4cfd91c23238a23806db,
title = "Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxide- induced brain damage in mice",
abstract = "The mechanism of neurodegeneration and the possible therapeutic amelioration were investigated in a model induced by successive carbon monoxide (CO) exposures. Successive CO exposures resulted in a consistent pattern of degeneration of hippocampal CA1 pyramidal cells, which was quantified using an image analyzer. Competitive and noncompetitive antagonists of N-methyl-D-aspartate (NMDA) receptors, cyclopentenophenanthrene, (+)-5-methyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten,5,10-imine maleate and an antagonist of glycine binding sites, 7-chlorokynurenic acid, significantly reduced the CO-induced neurodegeneration. Ifenprodil (a antagonist of polyamine binding sites) and glycine had no effect. From these results, it is clear that NMDA receptor/ion channel complex is involved in the mechanism of CO-induced neurodegeneration, and that glycine binding site antagonist as well as NMDA competitive and noncompetitive antagonists may have neuroprotective properties in neurological disorders associated with overactivation of NMDA receptors.",
author = "H. Ishimaru and A. Katoh and H. Suzuki and T. Fukuta and T. Kameyama and Toshitaka Nabeshima",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "261",
pages = "349--352",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxide- induced brain damage in mice. / Ishimaru, H.; Katoh, A.; Suzuki, H.; Fukuta, T.; Kameyama, T.; Nabeshima, Toshitaka.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 261, No. 1, 01.01.1992, p. 349-352.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxide- induced brain damage in mice

AU - Ishimaru, H.

AU - Katoh, A.

AU - Suzuki, H.

AU - Fukuta, T.

AU - Kameyama, T.

AU - Nabeshima, Toshitaka

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The mechanism of neurodegeneration and the possible therapeutic amelioration were investigated in a model induced by successive carbon monoxide (CO) exposures. Successive CO exposures resulted in a consistent pattern of degeneration of hippocampal CA1 pyramidal cells, which was quantified using an image analyzer. Competitive and noncompetitive antagonists of N-methyl-D-aspartate (NMDA) receptors, cyclopentenophenanthrene, (+)-5-methyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten,5,10-imine maleate and an antagonist of glycine binding sites, 7-chlorokynurenic acid, significantly reduced the CO-induced neurodegeneration. Ifenprodil (a antagonist of polyamine binding sites) and glycine had no effect. From these results, it is clear that NMDA receptor/ion channel complex is involved in the mechanism of CO-induced neurodegeneration, and that glycine binding site antagonist as well as NMDA competitive and noncompetitive antagonists may have neuroprotective properties in neurological disorders associated with overactivation of NMDA receptors.

AB - The mechanism of neurodegeneration and the possible therapeutic amelioration were investigated in a model induced by successive carbon monoxide (CO) exposures. Successive CO exposures resulted in a consistent pattern of degeneration of hippocampal CA1 pyramidal cells, which was quantified using an image analyzer. Competitive and noncompetitive antagonists of N-methyl-D-aspartate (NMDA) receptors, cyclopentenophenanthrene, (+)-5-methyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten,5,10-imine maleate and an antagonist of glycine binding sites, 7-chlorokynurenic acid, significantly reduced the CO-induced neurodegeneration. Ifenprodil (a antagonist of polyamine binding sites) and glycine had no effect. From these results, it is clear that NMDA receptor/ion channel complex is involved in the mechanism of CO-induced neurodegeneration, and that glycine binding site antagonist as well as NMDA competitive and noncompetitive antagonists may have neuroprotective properties in neurological disorders associated with overactivation of NMDA receptors.

UR - http://www.scopus.com/inward/record.url?scp=0026742194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026742194&partnerID=8YFLogxK

M3 - Article

VL - 261

SP - 349

EP - 352

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -